the e-cigarettes are the most commonly used drugs for smoking cessation and nicotine addiction. however, the effectiveness of cytisinicline is not well understood. in the last quarter, the e-cigarettes are now being used in the united states for smoking cessation and nicotine addiction, and the success of the e-cigarette trial has led to the development of cytisinicline. this quarter has been focused on the continuing analysis of the e-cigarettes trial and the progress of the phase 3 trial designs. in this article, we will discuss the main features of the second quarter and discuss the main issues involved in the development of cytisinically based on the results and the experience of the e-cigarette trial.